Related Experiment Video
Updated: Apr 15, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
MDM4 at the Crossroads: Beyond p53 and MDM2
Dipesh Thapa1,2, Allison St John1,2, Alejandro Parrales1
1Section of Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
Abstract:
MDM4 (Murine Double Minute 4), also known as MDMX, is a crucial negative regulator of the tumor suppressor p53. MDM4 heterodimerizes with MDM2 to enhance MDM2-mediated ubiquitination and degradation of p53, thereby promoting tumorigenesis. Beyond its canonical role in inhibiting p53 activity, recent studies have revealed diverse p53-independent functions. MDM4 interacts with various proteins, including p73, E2F1, casein kinase 1α, PPARα, and TRIM21 to regulate cell cycle progression, β-catenin-mediated pre-leukemic progression, and ferroptosis independent of p53. In addition, MDM4 functions independently of both p53 and MDM2 by interacting with proteins, such as SMAD family members 3/4, retinoblastoma protein (pRB), p21, Nbs1 (also known as Nibrin), mTOR complex 1 (mTORC1), and the Polycomb Repressive Complexes (PRCs) complex, to control cell proliferation and survival, as well as protein degradation, double-strand break (DSB) repair, and replication fork progression. Intriguingly, multiple studies suggest that MDM4 exhibits oncogenic activity independent of p53; however, other reports highlight a potential tumor-suppressive role for MDM4 in the absence of p53. Thus, MDM4's functions extend well beyond the canonical p53-MDM2 axis. A deeper understanding of MDM4 biology may facilitate the development of novel targeted therapies for various cancers.
Insights
Murine Double Minute 4 (MDM4) regulates tumor suppressor p53 but also has critical p53-independent roles. Understanding MDM4
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- MDM4 (Murine Double Minute 4) is a key negative regulator of the tumor suppressor p53.
- MDM4 collaborates with MDM2 to degrade p53, promoting tumor development.
- Emerging evidence highlights MDM4's significant p53-independent functions.
Purpose of the Study:
- To elucidate the diverse p53-independent roles of MDM4.
- To explore MDM4's interactions with various proteins beyond the p53-MDM2 axis.
- To understand MDM4's implications in cancer biology and therapeutic development.
Main Methods:
- Literature review and analysis of existing studies on MDM4.
- Identification of MDM4 interacting partners and their functional consequences.
- Comparative analysis of MDM4's roles in both p53-dependent and p53-independent pathways.
Main Results:
- MDM4 regulates cell cycle, pre-leukemic progression, and ferroptosis via p53-independent interactions (e.g., with p73, E2F1, TRIM21).
- MDM4 also controls proliferation, survival, DNA repair, and replication fork progression independently of p53 and MDM2 through interactions with SMADs, pRB, Nbs1, and mTORC1.
- MDM4 exhibits context-dependent oncogenic or tumor-suppressive activities independent of p53.
Conclusions:
- MDM4's biological functions extend significantly beyond its canonical role in inhibiting p53.
- MDM4's complex interactions and dual roles in cancer necessitate further investigation.
- Targeting MDM4 may offer novel therapeutic strategies for various cancers.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

